A little-known biotech stock has become a prime takeover target after surging nearly 1,700% last year
Europe’s best performing stock in 2025, Abivax, could be snapped up any day now, analysts say.
原文: https://www.cnbc.com/2026/01/09/abivax-deal-biotech-takeover-eli-lilly-jp-morgan-2026.html
Last Update:
9 1 月, 2026